IV medication Solution Compatibility Chart for nurses

Solution Compatibility Chart

Intravenous Medication

     S      S      N      N      W     ⁄     ⁄     ⁄      W      W     0      /      /     2     5     1     5     5      D      D      D      D      D         4

        2

        1

        1

Acetazolamide

C

Acyclovir

C

C

C

        2

        1

     S      S      N      R     5      S      N     5      R      D      N     ⁄      R L      D         2

        1

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

Antithymocyte Globulin

C

C

C

C

C

C

C

C

Ascorbic Acid

C

C

C

C

C

C

C

C

Aztreonam

C

C

C

C

C

Calcium Chloride

C

C

C

C

Calcium Gluconate

C

C

Cefazolin Na

C

C

C

Cefoperazone Na

C

C

C

Cefotaxime Na

C

C

C

Cefotetan

C

Cefoxitin Na

C

C

C

C

C

C

C

C

Ceftazidime

C

C

C

C

C

C

C

Ceftizoxime Na

C

C

C

C

C

C

C

Ceftriaxone Na

C

C

Cefuroxime Na

C

C

C

C

C

C

C

C

Cimetidine

C

C

C

C

C

C

C

C

Clindamycin

C

C

C

C

C

Dexamethasone

C

Dobutamine HCl

C

C

C

C

C

Dopamine HCl

C

C

C

C

C

Doxycycline

C

Epinephrine

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C C

C

C

C

C

C

C

C

C

C

Gentamicin

C

C

C

C

C

C C

W

C W

C

C

C

C

W

C

C

W

C

C

W

C

W

C

W

C

C

C

Hydromorphone HCl

C

C

Imipenem-Cilastatin

C4

C4

Insulin (Regular)

CP

C

CP

C

Kanamycin

C

C

Labetalol

C

Lidocaine

CP

Magnesium Sulfate

C

C

C4

C

C

C

C1

C1

C1

C

C W

C

C

C C

C*

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C4

C4

C10 C

C

C

C

C

C

C

CP

C

C

C

C

C

C

C

C

C

C1

C4

C

C

C

C

C

C

CP

C

C

C

C

C

C

C

C

C

C

C

W

C C

C

C

C

C

C

C

C

C

C C C

C C

C C

C

C

C

C

C

C

C

C

C

C

C C

C

C

C C

C

C

C

Furosemide

C

C

C

C

C*

C

C

C

C

Meropenem

C

W

C

C

Folic Acid

C

C

C

C

C

Meperidine HCl

C

C

C

C

C

C

Fentanyl

Isoproterenol

C

        6

        1

C

C

C

C

C

C

C

Hydrocortisone Na Succinate

     M     ⁄     e     t     a     t     c     a      L     a      N

C

C

Famotidine

Hydrocortisone Phosphate

C

C

C

C

C

C

C

Heparin Na

C

C

C

     S      N      /      W      /     %     0     1     c    u     r      F

     S      N      /      W      /     %     0     1     g    u     s     t     r     e    v     n      I

C

Aminophylline

C

     R      L     5      D

     S      N      /      W     5      D      /     %     6     n     a     r     t    x     e      D

C

C C

C

C

C4

C4

C

C C1

C2

Mosby Mosby items and and derived derived items items © 2010 by Mosby, Mosby, Inc., Inc., an affilia affiliate te of Elsevier Elsevier Inc. Inc. Some material was previously published.

Intravenous Medication

     S      N      W     ⁄     ⁄      W      W     0      /     2     5     1     5      D      D      D      D         4

        2

        1

        1

Metoclopramide HCl Morphine

C C

     S      N      S     ⁄      R      S      /      N      R      L     5     5      S      N     5     5      R      D      D      N     ⁄      R L      D      D         2

        1

        2

        1

C

C

C

Multivitamin

C

C

Nafcillin Na

C

C

Nitroglycerin

C*

Norepinephrine

CP

Ondansetron HCl

C

Oxacillin Na

C

Pancuronium

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C*

CP

C

C

C

C

C

C

C

C

C

C

C C

C

C

C

C C C

C

C

C

C

C

C

C

C

C

C

Penicillin G, K

C

C

C

C

C

C

C

C

C

C

C

Pentobarbital Na

C

C*

C

C

C

C

C

C

C

C

C

C

C* C*

C

C

C

C

C

C

C

C

C

C

Potassium Phosphate

C

C

C

C

C

C

C

C

Prochlorperazine

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

CP

Pyridoxine HCl

C

C

Ranitidine

C

C

Sodium Acetate

C

C

C

C

C

C

C

C

C

C

C

C C

C

C

C

C

C

C

C

Sodium Chloride

C

C

C

C

C

C

C

C

C

C

C

Succinylcholine

C

C

C

C

C

C

C

C

C

C

Thiamine

C

C

C

C

C

C

C

C

C

C

Thiopental

C

C

C

C

C6

C

C

C

C

C

C

C

C

C

C*

C

Warfarin

C

C

Zidovudine

CP

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

Tranexamic Acid

C

C

C

C

C

C

C

C

W

NS

Sodium Bicarbonate

Trace Metals

C

C

C

C

Potassium Chloride

Propranolol

C

C

        6

        1

C

C

C

     M     ⁄     e     t     a     t     c     a      L     a      N

C

C

Potassium Acetate

     S      N      /      W      /     %     0     1     c    u     r      F

     S      N      /      W      /     %     0     1     g    u     s     t     r     e    v     n      I

C

C

C

C

C

Papaverine

Piperacillin/  Tazobactam

C

     S      N      /      W     5      D      /     %     6     n     a     r     t    x     e      D

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C

C C

C C

C

This chart is not all inclusive. It is based on manufacturer’s recommendations and Trissel’s. KEY C W D21 ⁄ 2W D5W D10W D5/ 1 ⁄ 4NS D5/ 1 ⁄ 2NS D5NS NS 1  ⁄ 2NS R LR D5R D5LR

Compatible* Dextran 6%/D5W/NS Dextran 6% in D5W or normal saline Compatible in water not NS 21 ⁄ 2% Dextrose in water Fruc 10%/W/NS Fructose 10% in water or normal saline 5% Dextrose in water 10% Dextrose in water Invert sug 10%/W/NS Invert sugar 10% in water or normal saline 5% Dextrose in 1 ⁄ 4 normal saline 5% Dextrose in 1 ⁄ 2 normal saline Na Lactate 1 ⁄ 6 M Sodium lactate 1 ⁄ 6 M 1 5% Dextrose in normal saline Stable for 1 hour 2 Normal saline Stable for 2 hours 4 1  ⁄ 2 Normal saline Stable for 4 hours 6 Ringer’s solution Stable for 6 hours 10 Lactated Lactate d Ringer’ Ringer’ss solutio solution n Stable for 10 hours P 5% Dextrose in Ringer’s solution Preferred diluent 5% Dextrose in Lactated Ringer’s solution *Compatibility in various concentrations may vary; consult pharmacist.

Mosby Mosby items items and derived derived items items © 2010 by Mosby, Mosby, Inc., Inc., an affili affiliate ate of Elsevie Elsevierr Inc. Some material was previously published.